ERBB2 and breast cancer: The stabilization of PRLR is also mediated by the human epidermal growth factor receptor 2 (HER2)-/RAS-signaling-induced inhibitory phosphorylation of GSK3β in breast cancer cells, and elevated PRLR levels are correlated with GSK3β inactivation in breast cancer specimens [112].